Macroscopic thrombus formation on angioplasty equipment following antithrombin therapy with enoxaparin.

Increasing evidence suggests that treatment with the low molecular weight heparin enoxaparin during percutaneous coronary intervention (PCI) is safe and effective. We evaluated the incidence and consequences of periprocedural macroscopic thrombus formation on PCI equipment following antithrombin therapy with enoxaparin. Between April 2003 and December 2004, all patients undergoing cardiac catheterization following antithrombin therapy with enoxaparin were evaluated. All patients had blood sampled at the onset of procedure for subsequent measurement of anti-factor-Xa levels. Of the 4,504 patients who underwent PCI during this period, in 122 (3%) the procedure was performed within 8 hr of treatment with subcutaneous enoxaparin and no additional unfractionated heparin (UFH) was used periprocedurally. Of these, macroscopic thrombus was observed on PCI equipment in 6 patients (5%) necessitating withdrawal of all catheters and wires. All patients had therapeutic anti-factor-Xa levels at the time of PCI, and had been treated with double antiplatelet therapy with aspirin and clopidogrel. No periprocedural thrombus was observed in 356 patients who were >12 hr of the last dose of enoxaparin and received UFH at the time of PCI. Following observation of thrombus, additional anticoagulation with UFH resulted in significant epistaxis in one patient. In another patient, the procedure was complicated by distal coronary embolization. Percutaneous coronary intervention following antithrombin therapy with enoxaparin is associated with a 5% incidence of macroscopic thrombus formation on PCI equipment. The necessity for subsequent exchange of all equipment and/or the need for additional anticoagulation may have disastrous consequences for the patient. Our findings suggest that the safety of antithrombin therapy with low molecular weight heparin during PCI requires further evaluation.

The use of multiple "buddies" during transradial angioplasty in a complex calcified coronary tree.

We report our experience in transradial coronary angioplasty on a tortuous, calcified coronary tree in a patient who had been turned down for surgical revascularization. In view of the complexity of the coronary anatomy, successful completion of the procedure required plaque modification with the use of rotational atherectomy in the left anterior descending coronary artery, and the use of an inflated buddy balloon in the circumflex artery. The latter represents a novel, simple, and inexpensive technique, which may allow successful advancing of coronary stents in calcified and tortuous coronary arteries.

Reduction of discomfort at sheath removal during transradial coronary procedures with the use of a hydrophilic-coated sheath.

Some patients experience discomfort at sheath removal during transradial procedures. We hypothesized that the use of a hydrophilic-coated sheath (HCS) would reduce the traction force needed at withdrawal and therefore the pain experienced by patients. Patients referred for coronary intervention were randomized to undergo transradial procedure with the use of HCS or with nonhydrophilic sheath (NHS). At removal of the sheath, peak traction force was recorded using an electronic traction gauge and patients were asked to quantify their pain. A total of 90 patients participated in the study. The mean +/- SD peak traction force at sheath removal was 265 +/- 167 g and 865 +/- 318 g in the HCS and NHS groups, respectively (69% reduction; P < 0.001). Mean maximal pain score was 0.6 +/- 1.2 and 4.8 +/- 2.9 in the HCS and NHS groups, respectively (88% reduction; P < 0.0001). Use of HCS for transradial procedures reduces considerably the traction force needed for sheath removal as well as pain experienced by patients when compared to NHS.

A model for evaluation of arterial thrombosis following interventional procedures.

A model to assess thrombus formation following vascular injury was evaluated using various interventional systems. The model consisted of a 'stretchable' shunt box that served as an arteriovenous shunt between the carotid artery and jugular vein in dogs. Arterial homografts obtained from both carotid and femoral arteries were mounted between two plastic connectors attached to either side of the shunt box. The opposing walls of the shunt box were then stretched apart to achieve the original length of the arteries. The arterial side of the box was connected to the ipsilateral carotid artery and the venous side was connected to the contralateral jugular vein. Haemostasis valves were placed at the exit ports on the venous side of the shunt box. These were used as an access to the various interventional catheters into the lumens of the homografts. Interventions were performed prior to initiating blood flow. After the interventions, 111indium-labelled platelets were injected on the arterial side of the shunt box and arterial blood flow initiated across the shunt. After one hour of circulation through the shunt box, the blood flow was interrupted, and the homografts were perfusion-fixed with glutaraldehyde and segments removed for radioactive counts and processed for histology. This shunt box was then used to compare platelet adhesion and thrombus formation after balloon angioplasty (BA) to direct laser (LA) and laser-thermal angioplasty (LTA). A total of 28 arteries were used from seven dogs. In each experiment, one homograft was used as control, and three other homografts were treated with either BA, LA or LTA. Following the interventions, 111indium-labelled platelets were injected and circulated for one hour using the dog's native circulation. Labelled platelet counts for BA (19102+/-4869/cm2; mean +/- SE) were significantly greater than LA (7038+/-980/cm2), thermal LTA (5189+/-1961/cm2), and control (1575+/-541/cm2), respectively (p<0.05, ANOVA). Histology examination showed few platelets at LA, LTA and control sites whereas extensive platelet adhesion was noted at BA treated sites. The model provided a means to conduct simultaneous comparison of several interventions under similar conditions. In this case thermal treatment of the arterial homografts had the least amount of platelet adhesion.

Vascular procedures that thermo-coagulate collagen reduce local platelet deposition and thrombus formation: laser and laser-thermal versus balloon angioplasty.

BACKGROUND AND OBJECTIVE: Exposure of the arterial wall matrix to blood leads to platelet deposition resulting in thrombosis. Because heat alters tissue matrix we proposed that heating reduces platelet deposition. STUDY DESIGN/MATERIALS AND METHODS: Sixty arterial homografts (15 dogs) were mounted in an arterio-venous "shunt." Interventions included balloon angioplasty (BA), direct laser (LA), laser-thermal (LTA), and combined LTABA. 111Indium-labeled platelets were circulated, radio activity measured, and homografts processed for histology. RESULTS: Radioactivity count (mean+/- SE) at BA sites (13,853+/-3,192 cpm/cm(2)) was greater than LA (7,038+/-981), LTA (5,294 +/-1,145), LTABA (6,176+/-1,571), and control (1,826+/-339), P<0.05. Electron microscopy showed fewer platelets at LA, LTA, and control than BA sites. BA spread the collagen on the arterial lumen while heat gelled collagen and confined it to the arterial media. CONCLUSIONS: Heating the artery and gelling collagen during LA, LTA, or LTABA significantly reduced thrombogenicity.

Peripheral artery recanalization in humans using balloon and laser angioplasty.

The treatment of patients with complex peripheral arterial disease and those who have had previous unsuccessful attempted revascularization procedures can be clinically challenging. Initial treatment was begun using therapy by percutaneous balloon and laser angioplasty, then proceeding to bypass surgery if severe ischemia persisted. Both percutaneous and cut-down approaches were used to access totally occluded arteries. An attempt was made to cross the occlusion mechanically with either a guide wire or an activated laser probe. If laser recanalization was not successful, the patient underwent bypass surgery or was managed with medication unless an amputation was necessary. Following initial screening of 381 patients, 115 procedures were performed on 103 patients. In 31 procedures (28 patients), only balloon angioplasty was performed. In 84 procedures (75 patients), laser recanalization was attempted: 55 percutaneously and 29 by cut-down. Overall technical success (crossing the obstruction without perforation) was 86/115 (75%). Technically successful procedures were characterized by shorter arterial occlusions than were technical failures (8.4 +/- 1 cm vs. 14.3 +/- 1.9 cm; p < 0.004). Clinical success (residual stenosis < 50%, symptom relief, improved ankle brachial index > or = 0.15, and no complications) was achieved in 22/31 (71%) of balloon angioplasty procedures alone. The stenoses decreased from 98 +/- 4% to 31 +/- 24%, p < 0.00001. Combined percutaneous laser and balloon angioplasty had a technical success of 36/55 (65%). Stenoses were reduced from 99 +/- 2% to 56 +/- 14% after laser angioplasty, to 30 +/- 15% after balloon angioplasty, p < 0.0001. Laser angioplasty performed via a cut-down had a clinical success of 9/29 (31%). However, major complications were rare. Device staging for treatment of peripheral vascular disease provides additional options for patients who are at high surgical risk and/or in whom standard therapy has failed.

Modification of atrioventricular conduction using a combined laser-electrode catheter.

Ablation of the AV junction is an accepted technique for the management of selected supraventricular tachyarrhythmias. Radiofrequency ablation appears to be safe and effective for AV junction ablation in most patients, but the need for firm tissue contact may make it less effective for ventricular tachycardia and certain ectopic/atrial tachycardias. Laser energy can also be delivered through a catheter, and thus it may be an attractive alternative energy source for ablation. A new laser-electrode catheter was developed for modification of conduction through the AV node as a model for ablation of an arrhythmia substrate. A window for delivery of continuous-wave Nd:YAG laser energy was placed between the two electrodes of a bipolar electrode catheter. In vitro studies using a matrix of power versus time were performed to determine the energy that would create lesions of the appropriate size in vivo. Using this information, advanced AV block was successfully created in 16 of 17 dogs (94%) with the laser-electrode catheter. Advanced AV block was successfully created in all four dogs in the chronic study, and it persisted for 1-24 weeks of follow-up until sacrifice of the animals. Histologic examination demonstrated discrete thermal damage at the AV junction with no instances of septal perforation in the acute studies or progressive necrosis in chronically maintained dogs. Advanced AV block may be produced consistently and safely in dogs using a combined laser-electrode catheter.

Laser recanalization of thrombosed arteries using thermal and/or modified optical probes; angiographic and angioscopic study.

The degree of residual stenosis by fresh thrombus after laser recanalization was compared by use of angiography and angioscopy. Fifteen NZW rabbits were used. Occlusive fresh thrombus in rabbit aorta was produced by mechanical deendothelialization and external constrictions simulating clinical situations. Argon laser angioplasty using microlens-tipped optical fiber and/or 2 mm hot-tip probe was done to recanalize thrombosed aorta in 10 animals. Two-mm hybrid probe was used in 5. Percent area stenosis (% AST) was derived by use of the mean radius method obtained by angiography of stenotic segments in two orthogonal views and/or from angioscopy. All 15 totally occluded vessels with fresh thrombus were recanalized. Four minor perforations occurred. Following argon laser angioplasty with the microlens optical fiber, percent stenosis was reduced to 53% in diameter by angiography and 66 in % AST by angioscopy, and to 48% and 55 respectively following hot-tip probe. After laser angioplasty with the hybrid probe, residual stenosis by fresh thrombus was 37% in diameter on angiography and 63 in % AST on angioscopy. Mean percent AST was 62% with angiography and 52% with angioscopy, and there was no correlation between them (r = -0.028). Angioscopy provided cross-sectional topographic views of thrombosed lumen and showed charring and shrinkage of thrombus following laser angioplasty. This study suggests that (1) continuous-wave laser angioplasty using modified optical fibers can recanalize thrombotic vascular occlusion, (2) laser angioplasty by hot-tip probe could evacuate fresh thrombus more than microlens fiber on angioscopy, and (3) angiographic % AST did not correlate with angioscopic % AST.

Temperature monitoring during peripheral thermo-optical laser recanalization in humans.

To determine probe temperature required to achieve laser thermal recanalization of human peripheral arteries, temperature was monitored at the probe tip using a K-type thermocouple and displayed on a computer screen in real-time in 21 procedures. Recanalization was performed using a Spectraprobe-PLR delivering both laser light and heat in patients with prolonged ischemic limb symptoms. Laser recanalization of totally occluded peripheral arteries (occlusion length = 5.3 +/- 3.8 cm) was done percutaneously (17 procedures) or intraoperatively (4 procedures), after unsuccessful attempts of recanalization using standard guide wire and balloon angioplasty techniques. Probes were activated using argon laser irradiation starting at 5 W and increased by 1-W increments until successful recanalization, or up to a maximum of 12 W. Laser recanalization was achieved in 16/21 (76%) procedures at a mean temperature of 178 +/- 120 degrees C (range 64-503 degrees C) and a mean time of 12.4 +/- 14.1 s. Eleven of the 16 (69%) recanalizations occurred at probe temperature lower than 160 degrees C. Recanalization was achieved at a mean power of 7 +/- 2 W. Perforation occurred in 6 arteries at peak probe temperatures ranging from 73 to 502 degrees C. Perforations occurred in 4 of 6 densely calcific vessels which required high probe temperatures (greater than 250 degrees C). An important feature of temperature monitoring was the immediate detection of probe dysfunction. Although recanalization temperature had a wide range, the majority of recanalizations occurred at probe temperature below 160 degrees C.(ABSTRACT TRUNCATED AT 250 WORDS)

Laser thermo-optical angioplasty in totally occluded peripheral arteries: immediate and short-term results.

(1) Laser thermo-optical angioplasty in totally occluded peripheral arteries permits recanalization of lesions which would have otherwise required surgical bypass procedures. (2) Technical success was accomplished more frequently in patients with shorter occlusions. The technical success range in totally occluded blood vessels is 70-80%. (3) Clinical success in the peripheral circulation requires balloon angioplasty in most cases. Laser angioplasty has yet to be evaluated as monotherapy. (4) The combination of laser and balloon angioplasty has not decreased the restenosis rate from that seen with balloon angioplasty alone. (5) Restenosis rate was not influenced by lesion length. (6) In a significant number of patients with a totally occluded vessel a surgical procedure was avoided by performance of a percutaneous therapy.